The effects of alteration of the CDK1 gene are seen in many cancer types, including esophageal adenocarcinoma, breast cancer, oral squamous cell carcinoma, and hepatocellular and pancreatic adenocarcinoma [47,48,49,50,51]. This evidence concerns the gene CDK1 and pancreatic adenocarcinoma.